The Gross Margin of Astrazeneca Pharma India Ltd (ASTRAZEN.NS) is 43.89%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 43.89% |
| 2024-03-31 | 47.66% |
| 2023-03-31 | 57.05% |
| 2022-03-31 | 54.62% |
| 2021-03-31 | 58.47% |
| 2020-03-31 | 58.87% |
| 2019-03-31 | 61.84% |
| 2018-03-31 | 59.29% |
| 2017-03-31 | 60.86% |
| 2016-03-31 | 60.51% |